Inventor
Michael Ohlmeyer
Inventor
Plainsboro, NJ, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds7%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07BGeneral methods of organic chemistry1%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,759,790Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents202010,744,141Compositions and methods for treating cancer202010,450,282Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols201910,351,511Cyclic vinylogous amides as bromodomain inhibitors201910,221,158Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents20199,937,186Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents20189,937,180Constrained tricyclic sulfonamides20189,884,806'Cyclic vinylogous amides as bromodomain inhibitors'20189,796,717'Tricyclic heterocycles as anticancer agents'20179,540,358'Tricyclic compounds as anticancer agents'20179,494,572'Method and compositions for treating cancer and related methods'20169,134,297'Method and compositions for treating cancer and related methods'20158,895,599'Lipoprotein lipase-activating compositions comprising benzene derivates'20148,759,352'1-(4-ureidobenzoyl)piperazine derivatives'20148,350,043'Azinone and diazinone V3 inhibitors for depression and stress disorders'20138,314,091'N-benzyl,N\'-arylcarbonylpiperazine derivatives'20128,288,371'Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation'20128,211,927'5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators'20127,989,459'Purinones and 1H-imidazopyridinones as PKC-theta inhibitors'20117,919,490'6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression'20117,915,268'8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression'20117,906,504'2-(1-oxo-1H-isoquinolin-2-yl)acetamide derivatives'20117,902,187'6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression'20117,884,109'Purine and imidazopyridine derivatives for immunosuppression'20117,820,649'Quinazolinone and isoquinolinone acetamide derivatives'20107,807,686'2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2020Based in Plainsboro, NJ, US· patent location history
2011Patents assigned to WYETH LLC (4)· patent assignee history
2012–2017Patents assigned to OHLMEYER MICHAEL (5)· patent assignee history
2012–2014Patents assigned to HO KOC-KAN (4)· patent assignee history
2012–2014Patents assigned to ANSARI NASRIN (3)· patent assignee history
2015–2020Patents assigned to ICAHN SCHOOL MED MOUNT SINAI (12)· patent assignee history
2020Based in New York, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ICAHN SCHOOL MED MOUNT SINAI | 12 | 2015–2020 |
| OHLMEYER MICHAELself | 5 | 2012–2017 |
| HO KOC-KAN | 4 | 2012–2014 |
| WYETH LLC | 4 | 2011 |
| ANSARI NASRIN | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Plainsboro, New Jersey, US | 25 | 2010–2020 |
| New York, New York, US | 1 | 2020 |